Dr. Martens plc Stock – Fundamental Analysis
Fundamental Data & Ratios (Balance sheet update: 6/27/2026)
| Balance Sheet | Total Assets | 877,300,000.00 | ROE | 41.21 % |
| Balance Sheet | Total Equity | 361,500,000.00 | ROA | 2.71 % |
| Cashflow | Capital Expenditures | -9,200,000.00 | P/FCF | 5.71 |
| Cashflow | Free Cash Flow | 116,300,000.00 | – | – |
| Cashflow | Operating Cash Flow | 125,500,000.00 | P/CF | 5.29 |
| Income | Earnings per Share (diluted) | 0.02 | Div. Yield | 4.41 % |
| Income | Net Income | 23,800,000.00 | P/E | 34.00 |
| Income | Shares Outstanding | 976,879,000.00 | P/B | 1.84 |
| Income | Total Revenue | 764,900,000.00 | P/S | 0.87 |
Ratios calculated on: 10/14/2026
Company Description
Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Its product segments include originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.drmartensplc.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more